Request for Information

API Supplies Products

Home / API Supplies / API Supplies Products
Product Therapeutic category DMF
Aminocaprioc acid Clotting promoter DMF Ready
Chlorzoxazone Muscle relaxant USDMF
Canagliflozin (Amorphous) Antidiabetic USDMF
Canagliflozin Hemihydrate Antidiabetic USDMF
Chlorpromazine Hydrochloride Antipsychotic USDMF
Dapsone Anti-Bacterial / Anti Acne USDMF
Doxercalciferol Hyperparathyroidism USDMF
Droxidopa Neurogenic orthostatic hypotension USDMF
Eslicarbazepine acetate Anticonvulsant USDMF
Emtricitabine Antiretroviral USDMF
Efavirenz Antiretroviral USDMF
Gabapentin Enacarbil Analgesic USDMF
Mycophenolate Mofetil Immunosuppressive agent DMF
Nimodipine Anti-hypertensive USDMF
Nitazoxanide Ant parasitic / Antiviral drug USDMF
Oseltamivir Phosphate Antiviral (Influenza) drug USDMF
Oxcarbazepine Anticonvulsant USDMF
Pimavanserin tartrate Typical antipsychotic USDMF
Pregabalin Muscle Relaxant USDMF/ CEP/ KDMF
Ranolazine Anti Anginal USDMF/ ASMF
Sitagliptin Hydrochloride Antidiabetic USDMF / ASMF
Sitagliptin Phosphate (mono) Antidiabetic USDMF / CEP
Tenofovir Disproxil Fumarate Anti HIV / AIDS USDMF
Trientine Hydrochloride Wilson's disease USDMF
Tolvaptan Hyponatremia USDMF
Terazosin Antihypertensive USDMF
Valacyclovir HCl monohydrate Antiviral Filed (US)

New Products (For Regulatory market)

Product Therapeutic category DMF
Carboprost Tromethamine Prostaglandin DMF Q2
Eltrombopag Olamine Thrombopoietin-receptor agonist DMF Q2
Levocetirizine Antihistamine USDMF Q2
Nitrofurantoin Macrocrystals Antibiotic for UT Infections USDMF Q2
Prazosin Hydrochloride Anti-hypertensive USDMF Q2
Ropinirole Hydrochloride Anti-Parkinson’s USDMF Q2
Fluvoxamine maleate SSRI Validation to be planned
Suggamdex Sodium Neuromuscular USDMF Q2
Spironolactone Anti-mineralocorticoid Under Development
Verapamil HCL Calcium-channel blocker Under Development
Ziprasidone Mesylate Trihydrate Anti-Schizophrenia USDMF Q2

Oncology Products (For Regulatory market)

Product Therapeutic category DMF
Bicalutamide Anti-Cancer To be filed
Erlotinib (Form A) Anti-Cancer Under Development
Bendamustine HCl Anti-Cancer Under Development
Cyclophosphamide ( Monohydrate) Anti-Cancer Under Development
Imatinib Mesylate (Beta Form) Anti-Cancer Under Development

New Products (For ROW)

Product Therapeutic category DMF
Bimatoprost IH Available
Brivaracetam ICH Available
Cetirizine USP Available
Chloprostenol Sodium USP / IH Available
Dinoprostone USP / IH Available
Doxazosin Mesylate IH Available
Latanoprost USP / IH Available
Misoprostol USP Available
Oclacitinib Maleate IH Available (Veterinary API)
Silodosin IH Available
Trazodone USP Available
Travoprost USP Available
Tafluprost IH Available
Vildagliptin IH Available
Ziprasidone DiHCL USP Available